On this episode of the Health & Veritas podcast, Howard Forman and Harlan Krumholz react to President Joe Biden’s declaration that the pandemic is over. Then they’re joined by Jonathan Rothberg, a Yale-trained scientist who has created new methods for sequencing DNA and founded a series of successful biotech companies.
In this episode of the Health & Veritas podcast, Howard Forman and Harlan Krumholz discuss Harlan’s large new study tracking the trajectory of patient safety in hospitals, and consider how individuals should respond to the latest COVID-19 variants. And they’re joined by Jennifer Miller, a Yale bioethicist and the director of the Good Pharma Scorecard, which evaluates the performance of pharmaceutical companies on measures like the transparency of clinical trials and the accessibility of medicines.
Nandish Poluru ’13 discusses the pharmaceutical industry’s unprecedented cooperative efforts to treat and prevent COVID-19.
As pharmaceutical companies work to develop potential vaccines and treatments for COVID-19, they are operating under extreme pressure—as well as the restrictions on movement and interaction that are affecting all of us.